Neurology News

The FDA has granted priority review to Reata Pharmaceuticals Inc.’s new drug application for omaveloxolone to treat patients with Friedreich’s ataxia.

Long-term supplementation with spermidine improved neither memory function nor biomarkers compared with placebo in older adults with subjective cognitive decline, according to results of a clinical trial published in JAMA Network Open.

Biotech company PharmaJet announced that its partner, the Institute for Molecular Medicine, was awarded a $12 million grant from the NIH National Institute on Aging for a vaccine to prevent Alzheimer’s disease.

Age variability in symptom onset of Alzheimer’s disease in those with Down syndrome was comparable to those who experienced autosomal dominant AD, while mortality was also similar, according to a study published in JAMA Network Open.

Presence of axonal phosphorylated transactive response DNA-binding protein 43, or pTDP-43, accumulation in intramuscular nerve bundles is a likely biomarker for patients diagnosed with ALS, according to a study published in JAMA Neurology.

One in four neurosurgery patients experience adverse events, of which 25% are attributable to human error, according to a study published in Brain and Spine.

Onset of seizures after stroke more than doubled the risk for dementia in young patients, according to a study published in Neurology.

Patients with CVD are 40% to 80% more likely to have comorbid obstructive sleep apnea, which in severe cases can cause them to stop breathing hundreds of times a night.

Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes was well tolerated and resulted in significantly reduced seizures, according to a study published in Brain and Development.

U.S. Surgeon General Vivek H. Murthy, MD, MBA, issued an advisory addressing the alarming rate of burnout among health care workers.